INT185519

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.12
First Reported 2005
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 5
Total Number 7
Disease Relevance 4.58
Pain Relevance 1.37

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

Vms1 (Mus musculus)
Pain Link Frequency Relevance Heat
transdermal 63 99.20 Very High Very High Very High
Serotonin 23 82.68 Quite High
Neurotransmitter 8 82.28 Quite High
cva 3 77.44 Quite High
Hippocampus 4 76.00 Quite High
depression 48 68.68 Quite High
Bioavailability 3 68.56 Quite High
headache 18 67.80 Quite High
tricyclic antidepressant 4 12.16 Low Low
antidepressant 8 10.44 Low Low
Disease Link Frequency Relevance Heat
Endometriosis (extended) 245 99.82 Very High Very High Very High
Sleep Disorders 32 99.76 Very High Very High Very High
Cognitive Disorder 48 95.24 Very High Very High Very High
Hot Flashes 109 94.40 High High
Adhesions 3 88.24 High High
Cv General 3 Under Development 3 77.44 Quite High
Gallbladder Disease 7 76.60 Quite High
Hyperlipidemia 3 75.76 Quite High
Sleep Initiation And Maintenance Disorders 12 75.20 Quite High
Increased Venous Pressure Under Development 14 74.36 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
This review examines the clinical data related to the use of the transdermal spray and topical emulsion ET to treat VMS associated with menopause.


VMS Binding (associated) of associated with transdermal and endometriosis (extended)
1) Confidence 0.12 Published 2010 Journal Int J Gen Med Section Body Doc Link PMC2880349 Disease Relevance 0.50 Pain Relevance 0.46
Presented here are summaries of the clinical trials evaluating the effects of transdermal estrogen spray and estradiol topical emulsion on VMS associated with menopause.
VMS Binding (associated) of associated with transdermal and endometriosis (extended)
2) Confidence 0.12 Published 2010 Journal Int J Gen Med Section Body Doc Link PMC2880349 Disease Relevance 0.48 Pain Relevance 0.45
This review evaluates the current literature assessing the use of these two newer formulations for the treatment of VMS associated with menopause.



VMS Binding (associated) of associated with endometriosis (extended)
3) Confidence 0.12 Published 2010 Journal Int J Gen Med Section Abstract Doc Link PMC2880349 Disease Relevance 0.17 Pain Relevance 0.13
Menopause-related VMS also may be associated with insomnia and disordered breathing at night.
VMS Binding (associated) of associated with endometriosis (extended) and sleep disorders
4) Confidence 0.06 Published 2005 Journal Health Qual Life Outcomes Section Body Doc Link PMC1190205 Disease Relevance 1.36 Pain Relevance 0.03
Effects of associated VMS on QOL
VMS Binding (associated) of
5) Confidence 0.06 Published 2005 Journal Health Qual Life Outcomes Section Body Doc Link PMC1190205 Disease Relevance 0.37 Pain Relevance 0.08
Costs associated with VMS and their treatment
VMS Binding (associated) of
6) Confidence 0.06 Published 2005 Journal Health Qual Life Outcomes Section Body Doc Link PMC1190205 Disease Relevance 0.87 Pain Relevance 0.12
Menopause-related VMS are very common and can be associated with a high patient and societal burden.
VMS Binding (associated) of associated with endometriosis (extended)
7) Confidence 0.04 Published 2005 Journal Health Qual Life Outcomes Section Body Doc Link PMC1190205 Disease Relevance 0.83 Pain Relevance 0.10

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox